Safety and effectiveness of omalizumab for the treatment of chronic urticaria in pediatric patients

BACKGROUND: Evidence on safety and effectiveness of omalizumab for treatment of chronic urticaria in pediatric patients is scarce and limited to case reports. In particular, drug survival of omalizumab has not yet been investigated, which is a key element in the evaluation of its clinical performanc...

Descripción completa

Detalles Bibliográficos
Autores principales: Dekkers, Coco, Alizadeh Aghdam, Mehran, de Graaf, Marlies, Knulst, André C., Meijer, Yolanda, van den Reek, Juul M. P.A., Stadermann, Marike B., Röckmann, Heike
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
ORIGINAL ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8248194/
https://www.ncbi.nlm.nih.gov/pubmed/33305439
http://dx.doi.org/10.1111/pai.13426

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8248194/
https://www.ncbi.nlm.nih.gov/pubmed/33305439
http://dx.doi.org/10.1111/pai.13426

Ejemplares similares